Bioverativ
Enjaymo
Manufacturer:
Bioverativ
Name:
Enjaymo
HCPCS Code Descriptor:
Injection, sutimlimab-jome, 10 mg
Category:
J Code
HCPCS:
J1302
NDC(s):
80203-0347-01
Primary Type:
Hematology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
Enjaymo is a Hematology drug manufactured by Bioverativ and administered via the Intravenous route of administration. The J Code: J1302 is aligned to the drug Enjaymo.